Approval · Notice of Compliance 8697 · 2007
REQUIP SR-24: Notice of Compliance 8697
Issued April 10, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8697
- Date
- April 10, 2007
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Antiparkinsonian agent, dopamine agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REQUIP SR-24 | 02293692 | — |
| REQUIP SR-24 | 02293706 | — |
| REQUIP SR-24 | 02293714 | — |
| REQUIP SR-24 | 02293722 | — |
Medicinal ingredients
- ROPINIROLE HYDROCHLORIDE 2 MG per TAB
- ROPINIROLE HYDROCHLORIDE 3 MG per TAB
- ROPINIROLE HYDROCHLORIDE 4 MG per TAB
- ROPINIROLE HYDROCHLORIDE 8 MG per TAB